# Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer

> **NCT02856100** · — · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 18 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 18F DCFPyL- Radiopharmaceutical

## Key facts

- **NCT ID:** NCT02856100
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-03
- **Primary completion:** 2019-01
- **Final completion:** 2020-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02856100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02856100, "Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02856100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*